H3D and LifeArc: A Collaborative Approach to Addressing the Silent AMR Pandemic
Monday, 25 November 2024, 16:00
H3D and LifeArc Collaborate
H3D and LifeArc are embarking on a significant partnership to address the escalating threat of antimicrobial resistance (AMR) in a comprehensive manner. This collaboration is set to establish the Centre for Translational AMR, which will focus on innovative solutions and effective strategies to combat this silent pandemic.
Key Objectives of the Partnership
- Research Development: Enhance research capabilities in AMR.
- Innovative Solutions: Develop new treatments for resistant infections.
- Public Health Impact: Mitigate the effects of AMR on global health.
H3D and LifeArc aim to lead a change in how we approach AMR, signaling a pivotal shift in public health methodologies aiming to save lives.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.